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1. Introduction 
14-3-2 Protein is an acidic protein of monomeric 
molecular weight about 46 000 + 2000 dalton, puri- 
fied from beef brain [ 11. Studies have been carried 
out on its specificity to the nervous tissue and have 
demonstrated that this protein is brain specific and 
present in all mammalian brains studied [2] . Further 
studies have been carried out on the localization 
within the nervous system, of 14-3-2 protein. It was 
concluded that it is primarily neuronal [3], as con- 
firmed later by studies on the expression of this pro- 
tein in neuroblastoma cells grown in culture [4] . 
A recent study [S] on the proteins pattern ob- 
tained from five subcellular fractions of the mouse 
brain substantiate a previous hypothesis of Packman 
et al. [6], on rabbit brain subfractions, suggesting 
14-3-2 protein as a major protein component among 
soluble proteins of synaptosomes. 
The present report intends to answer with quanti- 
tative data this hypothesis indicating that 14-3-2 pro- 
tein is highly concentrated among buffer soluble pro- 
teins of synaptosomes prepared from rat brains. 
2. Experimental 
Bovine 14-3-2 protein was prepared according to 
Grass0 et al. [l] , by an adaptation for this protein of 
the general purification scheme of acidic brain-spe- 
cific proteins described by Moore and McGregor [7]. 
Antisera (Ra 35 B6) to beef brain 14-3-2 protein 
were obtained from Dr. B.W. Moore [3]. 
For complement fixation assay we used the modi- 
fication of Moore and Perez [S] of the method de- 
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scribed by Wasserman and Levine [9]. Microcom- 
plement fixation reactions were performed in a final 
volume of 0.61 ml, using a 1: 500 dilution of antisera 
to beef brain 14-3-2 protein. 
For the preparation of synaptosomes from brains 
of young male Wistar rats we followed essentially the 
procedure of Cotman and Matthews [lo], using a 
sucrose-Ficoll (Pharmacia, Uppsala Sweden) gradient. 
The synaptosomal ayer was freed from Ficoll by 
resuspending it several times in 0.32 M sucrose fol- 
lowed by centrifugation. After the third wash the 
synaptosomal pellet was resuspended in 5 mM Tris 
buffer (pH 8.1) and the soluble proteins extracted by 
overnight dialysis at 0-4°C against the same buffer. 
The insoluble material was pelleted by centrifugation 
and re-extracted with the same buffer containing 
5 mM EDTA [ll]. 
Synaptosomal fractions were prepared for electron 
microscopy by fixation with 3% glutaraldeyde in 
phosphate buffer pH 7.2 containing 1.75% sucrose. 
Samples were post-fixed in 2% osmic acid, dehy- 
drated and embedded in Epon resin. Sections were 
stained, after being cut on a Sorvall MT2, with ura- 
nyl acetate and lead citrate and examined in a Philips 
300 electron microscope. 
Proteins were measured by the method of Lowry 
[ 121, after precipitation with 5% TCA in the cold 
(0.4”C). 
3. Results 
As experienced by Cotman and Matthews [ 1 l] , 
there are some variations in different Ficoll lots, 
therefore we checked the results of our preparations 
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Fig. 1. Electron micrograph (70 000 X) of synaptosome fraction from 7.5513% band of Ficoll-sucrose gradient. Several 
synaptosomes are seen. 
I 1 
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Fig. 2. Microcomplement futation reaction between anti- 
serum to beef-brain 14-3-2 protein and buffer extracts of rat 
synaptosomes (*), total brain (0) and purified beef-brain 
14-3-2 protein (0). A dihrtion of antiserum 1500 was used. 
In the experiment reported here the amount (0.4 ng) of 
reacting beef-brain 14-3-2 protein required to give 50% fixa- 
tion is assumed to be present as beef-brain equivalents, in 
the amount of cross-reacting rat-brain antigen giving 50% 
futation. (30 ng and 150 ng). 
at the electron microscope. As shown in fig. 1 the 
population of synaptosomes we obtained is relatively 
pure and the estimated purity falls within the limits 
set by these authors for the method, that is more 
than 70% of the subcellular structure are synapto- 
somes. 
A complement fixation reaction between extracts 
of rat brain synaptosomes and antisera to beef-brain 
14-3-2 protein is demonstrated (fig. 2). The values 
given for proteins extracted from synaptosomes have 
to be intended not in absolute, but relative terms, 
because of the serological cross-reaction between 
antiserum to beef brain 14-3-2 protein and the 
heterologous antigen present in the extract from rat 
brain. 
With this consideration in mind quantitative data 
on 14-3-2 protein distribution in different subcellular 
fractions is given in table 1. We considered it signifi- 
cant to our working hypothesis to measure 14-3-2 
protein in the following fractions: a) the supernatant 
fraction from which the mitochoncrial fraction, con- 
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Table 1 
Content of 14-3-2 protein relative to the content of soluble 
protein in various subfractions of rat brain. 
Fraction pg of 14-3-2 Protein*/ mg of 
soluble proteins 
a) Rat brain cytoplasm 4.09 f 2.23 
b) Synaptosomes cytoplasm 17.46 + 2.32 
c) EDTA extractable proteins 2.05** 
from synaptic plasma mem- 
branes 
‘Ihe values for 14-3-2 protein represent means (* S.E.M.) for 
5 assays. 
* In terms of beef-brain equivalents. 
** This value is based on 3 assays. 
taming synaptosomes, has been removed; b) the 
supernatant resulting from Tris buffer extraction of 
synaptosomes; c) the supernatant resulting from a 
second extraction of the synaptosomal plasma mem- 
branes in presence of EDTA. The results reported in 
table 1 clearly indicate that 14-3-2 protein is present, 
in synaptosomes, in higher concentrations than in any 
of the fractions considered. In fact the values (4 
pg/mg protein) obtained for soluble proteins are 
similar to those established for 14-3-2 protein in ex- 
tracts of brain cytoplasm (4-6 pg/mg) [3]. On the 
contrary 14-3-2 protein measurable in extracts of 
synaptosomal cytoplasm (17 pg/mg protein) is more 
than four times higher than that of total brain ex- 
tract. We think that to this value should be added the 
data for EDTA extractable proteins (2 pg/mg protein) 
since we think it may reflect trapped 14-3-2 protein 
more than membrane bound one. 
4. Discussion 
Among others, two groups have reported electro- 
phoretic studies on the soluble proteins composition 
of subcellular fractions of the brain [S, 61. Both 
Packman et al. [6] ; describing the electrophoretic 
pattern of proteins extracted from subcellular frac- 
tions of rabbit brain and Waehneldt et al. [5], study- 
ing those of the mouse, suggested the presence in 
synaptosomal extract of 14-3-2 protein in relatively 
high concentrations. Furthermore, it may well also be 
that one of the bands (probably band no. 2) present 
in quantities higher in the nerve endings than in the 
cell bodies of rat brain, as described by McBride and 
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VanTassel [13] , is 14-3-2 protein. However bands 
with identical mobility in polyacrylamide gel do not 
necessarily belong to identical proteins. Therefore the 
analyses, by microcomplement fixation assay of the 
specific neuronal marker, 14-3-2 protein, confirm and 
also give quantitative answers to the above mentioned 
hypothesis. 
Whether the difference in 14-3-2 protein concen- 
tration between synaptosomal buffer extracts and 
total brain extract is real, one must be in doubt. 
14-3-2 Protein is a neurinal component, therefore its 
concentration is expected to be higher in subcellular 
structure which should come from neurons. However 
by comparison of our data and data obtained mea- 
suring 14-3-2 protein in discrete areas of human brain 
[2], or in neurons dissected from freeze-dried sec- 
tions using Lowry’s methods [2], the hypothesis of 
14-3-2 protein preferentially localized in neurons, still 
stands. The protein is synthesized in the perykarion 
[ 141, transported to the nerve endings and there 
eventually accumulated. 
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